Evaluation of Resection Techniques for Pancreatic Tumors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

431 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-04-16

Study Completion Date

2025-04-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint.

The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hepatic Resection for Metastatic Pancreatic Cancer

NCT02892305

Pancreatic Neoplasms Neoplasm Metastasis Liver Metastases

ACTIVE_NOT_RECRUITING

Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate

NCT04802993

Pancreatic Ductal Adenocarcinoma

COMPLETED

Standardization of Surgery on the Pancreatic Cancer

NCT00679913

Pancreatic Cancer

COMPLETED PHASE3

Evaluation of the Results of Simultaneous Pancreatic and Hepatic Resections for Metastatic Neuroendocrine Tumors.

NCT05528614

Tumor of Pancreas

COMPLETED

Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head Cancer

NCT07232810

Pancreatic Head Cancer Pancreatic Ductal Adenocarcinoma

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The plan is to conduct a retrospective chart review of patients who have undergone pancreatic and liver resection by using Meditech and Epic. A non-identified database will be created after retrospectively reviewing each patient case involving pancreatic or liver resection at MDMC. The study period will start in January 2006 until December 2020. Variables will include demographics, clinical disease diagnoses, and operative parameters as well as indirect charges from the hospitalizations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery Liver Tumor Pancreas Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Resection techniques for pancreatic and liver tumors

to compare open versus minimally invasive pancreatic resection techniques and analyze the different outcome variables from the clinical standpoint

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

minimally invasive pancreatic resection techniques

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC)
* Patients 18 years old or older